0370 1500 100

Yogi Amin



I am a solicitor, Partner and the National Head of the Public Law & Human Rights department.

I specialise in a range of public law and civil liberties areas, including Court of Protection work. I advise clients, both individuals and businesses, and represent them in Court on a national basis.

Other areas I specialise in include:

  • Civil liberties and judicial review
  • Equality duties and human rights law
  • Access to NHS healthcare and medicines
  • Access to social care
  • Environmental and planning law disputes
  • Challenges to unlawful police action
  • State investigations and inquiries, including coronial inquests
  • Education law
  • Regulatory interference with the ability to work in a profession
  • Mental Capacity and best interests disputes/safeguarding vulnerable adults
  • Commercial judicial review and procurement disputes

Along with my team, I have acted in a number of widely reported legal cases in the above areas and have contributed to developing the law. I have significant expertise and experience in conducting judicial review cases.

I have a specialist practice in medical ethics and regularly represent parties in the Court of Protection/High Court.

I also regularly lecture in this field. Access to Medical treatment and other clinical disputes often raise legal arguments relating to ‘dignity’, the ‘right to life’ or the ‘right to healthcare’. These are emotive subjects and disputes that I am interested in helping achieve a positive outcome.

In this video, I talk about the different kinds of case that our team handles.



Yogi is "a ground-breaking lawyer, always looking for new areas where vulnerable clients need help" and is highlighted for his "huge amount of experience in Court of Protection work." "The good thing about him is that he focuses on what the client wants and how to get it. He is a really practical lawyer." "Everyone knows him as an innovative, sensible and brilliant lawyer," who "has years of experience fighting the corner for families and patients." – Chambers & Partners, 2017

Yogi has "unparalleled experience of really tricky cases involving mental health and mental capacity issues" – ​Legal 500 2016

"A master strategist in terms of cutting through difficult disagreements without having to go to court" and "Very knowledgeable in terms of the management of a case. Very capable." – Chambers & Partners 2016

"He's always there in the heart of the big cases; he works really hard and he's very switched-on." – Chambers & Partners 2015

"One of the most experienced and knowledgeable practitioners in the area" and "a great strategist" – Legal 500 2013

Read My Comments On The Latest News

  • 14/10/2016
    Public Law Expert Wins Bristol Law Society Award

    “We see every day how tirelessly Fiona and our team work on behalf of our clients, so we are immensely proud that her efforts have been publicly recognised. She is a force of nature when it comes to fighting for the rights of her clients and this is a tremendous achievement for Fiona. “Much of Fiona’s work is on behalf of vulnerable individuals who have nowhere else to turn. It is to her credit that she is so passionate about helping them to resolve their problems and she is incredibly determined to fight for their rights.”

    Continue Reading
  • 23/08/2016
    Justice Secretary Confirms Plans To Replace Human Rights Act With British Bill Of Rights

    Latest reports suggest that the European rights will remain in some form, which is good news for Britons as many remain unaware of the protection these rights offer. With uncertainty over many of our links with Europe and the European Convention on Human Rights caused by Brexit, it is important that there are clear plans to ensure our citizens' rights remain protected in law and not downgraded in any way by a move away from the Human Rights Act.

    Continue Reading
  • 16/08/2016
    “Unacceptable” Waiting Times For Autism Assessment In Yorkshire

    “Getting an early diagnosis is a critical milestone for people with autism and can unlock the door to identifying the right support. It’s unacceptable to see the findings of the research and the NHS must consider changes immediately. “We’ve worked with a number of clients who were not able to access NHS support and assessment for autistic disorders even though they showed many of the symptoms. With our help they’ve been able to access the support that they were previously denied and it’s made a big difference to their lives. “When your child is acting and behaving differently to other children it is a very challenging and worrying period for any parent and having to wait to see an expert and find out the answers you’re desperately searching for only make the process more fraught. “We understand that the NHS is under pressure in many areas but after setting a target of three months for an initial assessment it is worrying to see so many children in Yorkshire having to wait much longer than that. Such delays could be held to be unlawful.”

    Continue Reading
  • 20/05/2016
    NICE Rejects Use Of Breast Cancer Drug Perjeta On NHS

    “Assessing and ensuring that cancer patients receive access to essential medication is an incredibly difficult and emotive issue and unfortunately we have seen a number of cases where patients have been negatively affected by unfair restrictions or decisions made without proper consideration of the facts. “There has been a great deal of hope around the positive effects of Perjeta among those suffering with breast cancer in the UK as trials last year indicated it had a significant positive impact in women with HER2-positive breast cancer prior to surgery. “All breast cancer patients deserve to be able to access the very best treatment available to them and it can be devastating, both physical and emotionally, when access is denied.”

    Continue Reading

Send Us Your Enquiry

Enter your details below and one of our experts will endeavour to call you back as soon as possible.

© 2017 Irwin Mitchell LLP is Authorised & Regulated by the Solicitors Regulation Authority. Our Regulatory Information.